Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Trolox in Organoid and Antioxidant Research: Protocols & Pre
2026-07-31
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) is a gold-standard antioxidant for benchmarking and optimizing workflows in both organoid and redox biology research. This guide translates cutting-edge protocols and troubleshooting insights into practical steps, with a focus on maximizing reproducibility in high-throughput and mechanistic studies.
-
TCF25 Regulates Lysosomal Acidification in Glucose Starvatio
2026-07-31
Ren et al. reveal that TCF25 functions as a nutrient sensor coordinating metabolic adaptation and cell death through lysosomal acidification during glucose starvation. This mechanistic insight clarifies how prolonged nutrient stress triggers ferritinophagy and lysosome-dependent cell death, highlighting potential therapeutic targets for metabolic and ischemic diseases.
-
OPP Enables Precision Protein Synthesis Measurement in Immun
2026-07-30
Explore how O-propargyl-puromycin (OPP) is reshaping translational immunology. This article integrates mechanistic findings on mitochondrial integrity and protein synthesis in B cells, showcases experimental strategies using OPP, and offers strategic guidance for researchers seeking robust, scalable assays for dynamic proteomics.
-
Lithium-Driven Exosomal Wnt10a Secretion Enhances Osteogenes
2026-07-30
This study uncovers how lithium promotes bone regeneration by enhancing Rab11a-mediated exosomal Wnt10a secretion and activating Wnt/β-catenin signaling in bone mesenchymal stem cells. The mechanistic insights provide a foundation for precision engineering of exosome-based therapies to address challenging bone repair scenarios.
-
Dual Recombinase Tracing Disproves Postnatal Neo-oogenesis i
2026-07-29
A recent study by Xie, Zhou, and Zheng applied dual recombinase-mediated genetic tracing to rigorously evaluate whether new oocytes are generated in mice after birth. Their findings provide strong evidence against the occurrence of postnatal neo-oogenesis, even following targeted ovarian injury, refining the conceptual and experimental framework for mammalian reproductive biology.
-
Sodium Citrate in SERS Nanocluster Fabrication: Protocols &
2026-07-29
Sodium citrate, a versatile metal ion chelator and buffering agent, is pivotal for fabricating highly reproducible and sensitive SERS nanocluster substrates. This article unpacks practical workflows, protocol parameters, and troubleshooting strategies that leverage sodium citrate’s unique properties for advanced surface-enhanced Raman scattering applications.
-
Reliable Assays with 10 mM dNTP (2'-deoxyribonucleoside-5'-t
2026-07-28
This article explores how the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture (SKU K1041) addresses persistent challenges in cell-based assays and DNA synthesis workflows. Through five real-world lab scenarios, we highlight how this product supports reproducibility, substrate consistency, and protocol robustness for biomedical researchers. Data-backed protocol recommendations and comparative analysis guide scientists toward evidence-based adoption of SKU K1041.
-
(S)-Mephenytoin: CYP2C19 Substrate for Advanced Organoid PK
2026-07-28
(S)-Mephenytoin stands out as a gold-standard CYP2C19 substrate, enabling robust, quantitative assessments of oxidative drug metabolism in next-generation in vitro models. Harness its full potential in hiPSC-derived intestinal organoids to bridge the translational gap between bench and clinic, overcoming the limitations of legacy cell lines and animal models.
-
Cy5.5 NHS Ester: Advanced Near-Infrared Labeling for Imaging
2026-07-27
Cy5.5 NHS ester (non-sulfonated) empowers highly sensitive, deep-tissue in vivo fluorescence imaging and quantitative tracking of biomolecules. This article translates bench research and recent innovations into actionable workflows, troubleshooting guidance, and protocol optimization for advanced molecular and cellular biology applications.
-
VX-745: Protocols and Innovations for p38α MAPK Inhibitor Re
2026-07-27
VX-745 stands out as a potent, selective p38α MAPK inhibitor, enabling researchers to dissect inflammatory and cancer pathways with unprecedented precision. This guide details optimized protocols, dual-action mechanistic insights, and troubleshooting strategies for maximizing the translational and experimental impact of VX-745 in cellular and animal models.
-
Clozapine N-oxide: Precision Chemogenetics in Neuroscience
2026-07-26
Clozapine N-oxide (CNO), supplied by APExBIO, is a cornerstone for non-invasive, reversible modulation of neuronal circuits. This article details experimental workflows, troubleshooting, and novel applications, highlighting CNO’s pivotal role in advancing chemogenetic and GPCR signaling research.
-
(-)-Epigallocatechin Gallate (EGCG): Neuroprotective Mechani
2026-07-25
Explore the unique neuroprotective and antioxidant mechanisms of (-)-Epigallocatechin gallate (EGCG), the major green tea catechin, in the context of neurodegenerative disease modeling and translational research. This in-depth analysis reveals how EGCG’s molecular actions open new avenues beyond cancer and tissue engineering applications.
-
O6-Benzylguanine: Strategic MGMT Inhibition in Translational
2026-07-24
This thought-leadership article explores the mechanistic and translational value of O6-Benzylguanine as a benchmark MGMT inhibitor, integrating recent breakthroughs in MGMT regulation, practical assay guidance, and actionable research strategies. Backed by new evidence on AP-2α–MGMT axis modulation in recurrent glioblastoma, it provides a strategic roadmap for researchers tackling chemoresistance in cancer therapy. The discussion uniquely bridges mechanistic insight with workflow optimization, differentiating itself from standard product literature.
-
Lithium-Driven Exosomal Wnt10a Release Promotes Osteogenesis
2026-07-24
A recent study demonstrates that lithium enhances osteogenesis by promoting Rab11a-mediated exosomal Wnt10a secretion, leading to activation of Wnt/β-catenin signaling in bone mesenchymal stem cells. This mechanistic insight highlights new strategies for engineering cell-based therapies to improve bone regeneration.
-
AM251 in Neurocircuit Dissection: Beyond Standard CB1 Antago
2026-07-23
Discover how AM251, a potent CB1 receptor antagonist, enables precise dissection of endocannabinoid signaling in both neuropharmacology and metabolic research. This article provides advanced insights for neuroscience research, focusing on network-level modulation and translational assay design.